Summary NeuroMetrix, Inc. (NeuroMetrix) is a healthcare company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company's products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNCheck and advance NCS system. Its SENSUS pain therapy and NC-stat DPNCheck are used for the treatment of diabetic peripheral neuropathy. NeuroMetrix has expertise in basic and clinical neurophysiology, biomedical engineering and instrumentation, and information technology. The company caters to clinics, hospitals, managed care organizations, retail health businesses, and durable medical equipment suppliers. It markets its products through distributors in the US, Europe, Asia, and the Middle East. NeuroMetrix is headquartered in Waltham, Massachusetts, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company NeuroMetrix, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 NeuroMetrix, Inc. Company Snapshot 6 NeuroMetrix, Inc. Company Overview 6 NeuroMetrix, Inc. Pipeline Products and Clinical Trials Overview 7 NeuroMetrix, Inc.- Pipeline Analysis Overview 9 Key Facts 9 NeuroMetrix, Inc. - Major Products and Services 10 NeuroMetrix, Inc. Pipeline Products by Development Stage 11 NeuroMetrix, Inc. Clinical Trials by Trial Status 13 NeuroMetrix, Inc. Pipeline Products Overview 14 DPN - Fall Prevention 14 DPN - Fall Prevention Product Overview 14 DPN - Foot Ulcer Healing 15 DPN - Foot Ulcer Healing Product Overview 15 Intra-Operative Peripheral Nerve Assessment and Monitoring Device 16 Intra-Operative Peripheral Nerve Assessment and Monitoring Device Product Overview 16 NeuroMetrix Navigator 17 NeuroMetrix Navigator Product Overview 17 Quell Platform - Digital Electrode 18 Quell Platform - Digital Electrode Product Overview 18 Quell Platform - Smartphone Control 19 Quell Platform - Smartphone Control Product Overview 19 Second-generation NC-stat DPNCheck Device 20 Second-generation NC-stat DPNCheck Device Product Overview 20 SENSUS Assistant 21 SENSUS Assistant Product Overview 21 SENSUS RLS 22 SENSUS RLS Product Overview 22 SENSUS RLS Clinical Trial 23 NeuroMetrix, Inc. - Key Competitors 24 NeuroMetrix, Inc. - Key Employees 25 NeuroMetrix, Inc. - Locations And Subsidiaries 26 Head Office 26 Recent Developments 27 NeuroMetrix, Inc., Recent Developments 27 Jun 02, 2016: NeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug Stores 27 May 26, 2016: NeuroMetrix Reports the Launch of the Quell Health Cloud for Android 27 May 18, 2016: NeuroMetrix Announces Frank McGillin, SVP and General Manager, Consumer to participate in a Digital Health Summer Summit Panel at BIO 2016 27 May 16, 2016: NeuroMetrix Announces Availability of Quell at Brookstone 28 Apr 21, 2016: NeuroMetrix Reports Q1 2016 Financial Results and Highlights 28 Mar 28, 2016: NeuroMetrix Showcases Quell Technology at the Midwest Podiatry Conference 28 Mar 17, 2016: NeuroMetrix Announces Availability of Quell at Target 29 Mar 16, 2016: Quell Named Best Wearable Technology in 2016 SXSW Interactive Innovation Awards 29 Mar 10, 2016: NeuroMetrix Showcases Quell Wearable Pain Relief Technology at the 2016 SXSW Show 30 Mar 02, 2016: NeuroMetrix Announces Availability of the Newest Version of Quell Wearable Pain Relief Technology 30 Appendix 31 Methodology 31 About GlobalData 31 Contact Us 31 Disclaimer 31
List of Tables
NeuroMetrix, Inc. Pipeline Products and Clinical Trials Overview 7 NeuroMetrix, Inc. Pipeline Products by Equipment Type 7 NeuroMetrix, Inc. Pipeline Products by Indication 8 NeuroMetrix, Inc. Clinical Trials by Trial Status 8 NeuroMetrix, Inc., Key Facts 9 NeuroMetrix, Inc., Major Products and Services 10 NeuroMetrix, Inc. Number of Pipeline Products by Development Stage 11 NeuroMetrix, Inc. Pipeline Products Summary by Development Stage 12 NeuroMetrix, Inc. Clinical Trials by Trial Status 13 NeuroMetrix, Inc. Clinical Trials Summary 13 DPN - Fall Prevention - Product Status 14 DPN - Fall Prevention - Product Description 14 DPN - Foot Ulcer Healing - Product Status 15 DPN - Foot Ulcer Healing - Product Description 15 Intra-Operative Peripheral Nerve Assessment and Monitoring Device - Product Status 16 Intra-Operative Peripheral Nerve Assessment and Monitoring Device - Product Description 16 NeuroMetrix Navigator - Product Status 17 NeuroMetrix Navigator - Product Description 17 Quell Platform - Digital Electrode - Product Status 18 Quell Platform - Digital Electrode - Product Description 18 Quell Platform - Smartphone Control - Product Status 19 Quell Platform - Smartphone Control - Product Description 19 Second-generation NC-stat DPNCheck Device - Product Status 20 Second-generation NC-stat DPNCheck Device - Product Description 20 SENSUS Assistant - Product Status 21 SENSUS Assistant - Product Description 21 SENSUS RLS - Product Status 22 SENSUS RLS - Product Description 22 SENSUS RLS - Use of Wearable Pain Relief Technology in Restless Leg Syndrome 23 NeuroMetrix, Inc., Key Employees 25
List of Figures
NeuroMetrix, Inc. Pipeline Products by Equipment Type 8 NeuroMetrix, Inc. Pipeline Products by Development Stage 11 NeuroMetrix, Inc. Clinical Trials by Trial Status 13
Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growiRead More...
Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energRead More...
Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.Read More...
Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the glRead More...
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.